PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Relationship Between "FODMAPs" and "GVHD"
- Status
- RECRUITING
- Phase
- N/A
Cellular Stress Reactions During Graft-versus-host Disease
- Status
- COMPLETED
- Phase
- N/A
Identification of Novel Targetable Kinases in SR-a GvHD
- Status
- COMPLETED
- Phase
- N/A
Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
The Skin Microbiome in Graft Versus Host Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Optimizing PTCy Dose and Timing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors
- Status
- COMPLETED
- Phase
- N/A
Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
- Status
- RECRUITING
- Phase
- N/A
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
- Status
- TERMINATED
- Phase
- PHASE3
Dynamic of Immunocompetent Populations in Patients Treated With Extracorporeal Photopheresis in Chronic Graft Versus Host Disease
- Status
- TERMINATED
- Phase
- N/A
Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT)
- Status
- COMPLETED
- Phase
- N/A
Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD)
- Status
- TERMINATED
- Phase
- PHASE2
Detection of Graft Versus Host Disease With [18F]F-AraG
- Status
- COMPLETED
- Phase
- PHASE1
Cryopreservation of White Blood Cells Before Their UVA Irradiation for Graft Versus Host Disease Treatment
- Status
- UNKNOWN
- Phase
- NA
Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
- Status
- TERMINATED
- Phase
- PHASE2